Does dabigatran improve stroke prevention in atrial fibrillation? A rebuttal.

Vitamin K antagonists (VKAs) are well established for the prevention of stroke or other embolisms in atrial fibrillation (AF) patients. Despite their efficacy, VKAs are underused in AF patients, especially in those who may benefit most, such as patients with advanced age or previous stroke. If VKAs are used, patients are within the therapeutic International… CONTINUE READING